October 28, 2019

Episode 4

Stephen Harrison, MD, from Pinnacle Clinical Research, highlights the importance of new treatment options for patients with nonalcoholic steatohepatitis, findings from the REGENERATE clinical trial that were presented at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting and Postgraduate Course, and more.

Stephen Harrison, MD, is medical director of Pinnacle Clinical Research in San Antonio, Texas, and a visiting professor of hepatology at the University of Oxford in Oxford, England

Listen to the full series!